Fulgent Genetics Inc (FLGT)

Receivables turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Revenue (ttm) US$ in thousands 289,213 286,412 307,380 364,868 618,968 802,935 925,148 953,423 992,584 1,035,891 909,739 773,388 421,712 135,121 43,752 34,911 32,528 29,814 25,092 22,068
Receivables US$ in thousands 52,451 50,392 35,719 44,365 72,585 104,858 134,637 161,766 140,315 122,629 150,015 216,510 201,667 99,094 13,907 6,403 6,571 5,319 5,576 4,580
Receivables turnover 5.51 5.68 8.61 8.22 8.53 7.66 6.87 5.89 7.07 8.45 6.06 3.57 2.09 1.36 3.15 5.45 4.95 5.61 4.50 4.82

December 31, 2023 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $289,213K ÷ $52,451K
= 5.51

Fulgent Genetics Inc's receivables turnover has shown fluctuations over the past eight quarters. The highest receivables turnover ratio was observed in Q4 2022 at 8.24, indicating that the company collected its receivables approximately 8.24 times during that quarter. This was followed by a notable decrease in Q1 2023 to 7.57 and further declines in subsequent quarters until Q3 2023 (5.24).

The receivables turnover ratio rebounded significantly in Q4 2023 to 5.66, suggesting that the company improved its efficiency in collecting outstanding receivables compared to the previous quarter. Despite the fluctuations, the overall trend seems to show a degree of variability in Fulgent Genetics Inc's ability to collect its receivables promptly.

It is important to further investigate the reasons behind these fluctuations to determine if they are driven by changes in credit policies, customer payment behavior, or other external factors that may impact the company's cash flow and working capital management.


Peer comparison

Dec 31, 2023